Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction-Reference-Cited by-同舟云学术

Repurposing FDA-approved drugs for SARS-CoV-2 through an ELISA-based screening for the inhibition of RBD/ACE2 interaction

Published:2020-11-18 Issue:7 Volume:12 Page:586-591
ISSN:1674-800X
Container-title:Protein & Cell
language:en
Short-container-title:Protein Cell

Author:

Fu Wenyu,Chen Yujianan,Wang Kaidi,Hettinghouse Aubryanna,Hu Wenhuo,Wang Jing-Quan,Lei Zi-Ning,Chen Zhe-Sheng,Stapleford Kenneth A.^ORCID,Liu Chuan-ju^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Drug Discovery,Biochemistry,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s13238-020-00803-w.pdf

Reference15 articles.

1. Castañeda-Arriaga R, Pérez-González A, Galano A (2018) Chemical Protectors against the Toxic Effects of Paracetamol (Acetaminophen) and Its Meta Analogue: Preventing Protein Arylation. ACS Omega 3:18582–18591

2. De Flora S, Grassi C, Carati L (1997) Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. Eur Respir J 10:1535–1541

3. Geiler J, Michaelis M, Naczk P, Leutz A, Langer K, Doerr HW, Cinatl J Jr (2010) N-acetyl-L-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus. Biochem Pharmacol 79:413–420

4. Ghezzi P, Ungheri D (2004) Synergistic combination of N-acetylcysteine and ribavirin to protect from lethal influenza viral infection in a mouse model. Int J Immunopathol Pharmacol 17:99–102

5. Gordon DE, Jang GM, Bouhaddou M, Xu J, Obernier K, White KM, O’Meara MJ, Rezelj VV, Guo JZ, Swaney DL et al (2020) A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583:459–468

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Natural Bioactive Peptide from Pinctada fucata Pearls Can Be Used as a Potential Inhibitor of the Interaction between SARS-CoV-2 and ACE2 against COVID-19;International Journal of Molecular Sciences;2024-07-19

2. Screening and identifying natural products with SARS-CoV-2 infection inhibitory activity from medicinal fungi;Biosafety and Health;2023-12

3. Effect of the N501Y Mutation on Ligands Complexed with SARS-CoV-2 RBD: Insights on Potential Drug Candidates for COVID-19;Drugs and Drug Candidates;2023-05-30

4. Virus-like Plasmonic Nanoprobes for Quick Analysis of Antiviral Efficacy and Mutation-Induced Drug Resistance;Analytical Chemistry;2023-03-09

5. A Survey on Offline Reinforcement Learning: Taxonomy, Review, and Open Problems;IEEE Transactions on Neural Networks and Learning Systems;2023